INTRODUCTION
Hyperphosphataemia is one of the commonest biochemical abnormalities in chronic kidney disease and poses significant challenges for management. Epidemiological and observational studies have shown a strong association between hyperphosphataemia and mortality in dialysis patients. 1 Adequate control of serum phosphate levels in patients undergoing haemodialysis (HD) is poorly achieved. 2 Reasons proposed for this are multifactorial and include poor knowledge of consequences of phosphate control, poor understanding of the low phosphate diet and poor adherence with the diet and phosphate binders. 3 Low phosphate diets are complex and may compromise protein intake; thus, increasing the risk of malnutrition in this vulnerable group. Increased level of phosphate restriction may be associated with greater mortality in some subgroups of patients. 4 Several studies have highlighted the lack of knowledge as a contributory factor to poor phosphate control. Cupisti et al. 5 found that phosphate nutrition knowledge of HD patients was much lower than that of the dialysis nurses, and patients with hyperphosphataemia had similar knowledge levels to those with normal serum phosphate. Toussaint et al. 3 found that of 136 patients surveyed, 42% were unsure of high phosphate foods, and 46% were unaware of the consequences of elevated phosphate.
Non-adherence persists as one of the most challenging tasks in the health care of patients with chronic conditions, including HD patients. A cross-sectional study of 456 HD patients in the USA and Germany found that self-reported non-adherence to diet was 80.4%. 6 Nerbass et al. 7 found that 87% of a sample of 117 hyperphosphataemic patients admitted non-adherence to diet and phosphate binders. Factors that hinder dietary adherence include the patients' educational level, socio-economic level, multiple comorbidities, difficulty in differentiating food that is a source of potassium and phosphorus and functional ability to prepare meals. 8 Complexity of the patient's regimen in terms of number and timing of medications, multiple dietary restrictions and a demanding dialysis regimen can affect adherence. 9 Adherence to phosphate-binding medication poses a particular challenge due to the complexity of the regime and lack of perceived symptomatic effect. 10, 11 A systematic review of prevalence and determinants of non-adherence to phosphate binders 11 found that reported rates of non-adherence varied from 22 to 74% and were associated with younger age and psychological variables such as patients' beliefs, social support and personality characteristics.
There is little data exploring the impact of age on multifactorial influences on phosphate management. The aims of this study were to compare serum phosphate levels and other associated 1 biochemical parameters with the UK Renal Association Clinical Practice Guidelines and examine the factors associated with poor phosphate control in different age groups of HD outpatients.
MATERIALS AND METHODS Participants
In May 2011, an audit of all HD patients (n ¼ 130) who attended the Plymouth Dialysis Unit was carried out to compare phosphate and associated biochemical parameters with the Renal Association Clinical Guidelines. 2 The current protocol on this unit requires HD patients to be seen every 6 months by the dietitian for individualised nutrition counselling and patients with hyperphosphataemia to be seen monthly. Any HD patients who were admitted as an inpatient during this time were excluded from the audit.
Data collected for audit
The following data were collected for the audit: age, gender, ethnicity, years on dialysis, serum phosphate, corrected calcium, urea reduction ratio, parathyroid hormone, presence and type of diabetes, incidence of parathyroidectomy (PTX), HD shift, prescribed dialysis time and prescription of phosphate binders, active vitamin D and cinacalcet. Biochemical data were collected from the hospital pathology laboratory and medical information was collected from the medical notes and dialysis records. An anonymous service evaluation questionnaire was developed to explore patients' knowledge, for example, patients were asked to identify the consequences of hyperphosphataemia, foods high in phosphorus and the correct time to take their phosphate binders. In addition, patients were asked whether they used Renal Patient View, a database that provides online information about their latest biochemical data and patients perception of which members of the renal team provide the most useful information on phosphate management. The questionnaire was administered face-to-face during HD sessions by independent researchers.
Statistical analysis
Data were analysed using SPSS, version 18.0. Normality of serum phosphate distribution was assessed using the Kolmogorov-Smirnov test. Data were transformed to logarithms to symmetrise the distribution (P40.05). Independent samples t-tests were conducted to identify differences between serum phosphate levels and a number of patient groupings. Secondary analysis was conducted by grouping serum phosphate levels as controlled (within range) or not controlled (out of range). The Pearson w 2 test was utilised to identify trends between phosphate control and a number of patient groupings. For all analyses, Po0.05 was considered statistically significant.
Ethical considerations
Ethical approval was granted by Plymouth University Undergraduate Ethics Committee. Approval for the clinical audit was also sought and approved by the Plymouth Hospitals NHS Trust. Verbal consent was obtained from the patients.
RESULTS
Of the 130 patients included in the audit, 5 were admitted as inpatients therefore excluded from the data analysis. An additional 4 patients were too unwell to complete the service evaluation questionnaire. Twenty patients had missing biochemical data and medical notes were unavailable for some patients. The patients' demographic details are shown in Table 1 . The majority of the patients were white, with 60% X65 years, and approximately twothirds male and one-third female. Approximately half of the patients had been attending HD for between 1 and 5 years and one-third had the diagnosis of diabetes (Type 1 and 2). Of those with Type 2 diabetes, 34% were under 65 years of age and the remaining 66% were 65 years or over.
Approximately half (53%) and three quarters (77%) of the patients had serum phosphate and serum calcium levels within the recommended targets, respectively. The majority of the patients had a parathyroid hormone level within the recommended range (85%) and met the target for urea reduction ratio (79%) (see Table 2 ).
Food and symptom knowledge A quarter of patients (23%, n ¼ 21) were unable to correctly identify foods high in phosphorus. The most frequently recognised food that was high in phosphorus was cheese (66%, n ¼ 61) and the least frequently recognised food was yogurt (24%, n ¼ 22). There was some confusion as to which foods were high in phosphorus, as over half of the patients selected the food banana as being high in phosphorus (58%) and 25% and 5% selected butter and carrots, respectively, as being high (Figure 1) .
The most frequently recognised symptom of hyperphosphataemia was itching (28%, n ¼ 53). Interestingly, tiredness (27%, n ¼ 52) and nausea (7.5%, n ¼ 14) were also reported as symptoms. A small proportion (4%, n ¼ 5) reported that they were unsure if there were any consequences ( Figure 2 ).
Factors associated with phosphate control Three quarters (n ¼ 84) of the patients were prescribed phosphate binders. There was no significant association between phosphate control and being prescribed phosphate binders, w 2 (1, n ¼ 112) ¼ 2.29, P ¼ 0.13. Of patients who reported they were taking phosphate binders, only approximately half (45%, n ¼ 44) reported taking them 'exactly as prescribed'. The main reason given for not taking the binders 'exactly as prescribed' was that they forgot to take them (76%, n ¼ 28). The majority of patients knew that they should take their phosphate binders with 'each main meal' (87.1%, n ¼ 74); however, only a quarter were aware that these should also be taken 'with snacks containing phosphate' (22%, n ¼ 19). Although under 65 years old had significantly better knowledge of which foods contained phosphorus (Po0.001) and were significantly more aware of the symptoms of hyperphosphataemia (Po0.001), their phosphate levels were significantly higher than those X65 years old (Po0.001) (see Table 3 ). When patients were asked whether they wanted more information on phosphate control and the effects of hyperphosphataemia on health, approximately half of 18-65 years old (42%, n ¼ 20) and over 65 year olds (48%, n ¼ 35) said yes.
The type of information that the patients found most useful to help them control phosphate levels was verbal information from the dietitian (39.4%, n ¼ 69) and leaflets to take away reported as the next most useful (29.1%, n ¼ 51). Patients' own research was thought to be the least useful (6.9%, n ¼ 12).
DISCUSSION

Hyperphosphataemia, defined by the Renal Association Clinical
Guidelines as 41.7 mmol/l 2 , is a common secondary complication in established renal failure. Approximately half of the patients in this audit had a serum phosphate levels within the recommended target range of 1.1-1.7 mmol/l, clearly emphasising that controlling serum phosphate levels is challenging. This compares to the latest national Renal Registry data from 2011 when 56% fell within the then target of 1.1-1.7 mmol/l. 12 Consequently these patients are at greater risk of renal bone disease, calcification of soft tissue and increased mortality. 1 Interestingly, when phosphate levels were grouped into 'within' and 'out of' range, significant associations were found with age, diabetic status and incidence of PTX. The older patients, as compared with the younger patients, were more likely to have phosphate levels within the recommended range. This finding is supported by previous findings that older age is associated with higher levels of adherence to phosphate treatment regimens. 11, 13 These findings could also be influenced by a reduction in food intake, in particular protein intake, in the elderly and more structured food intake. 14 The finding that patients with diabetes were more likely to have within range phosphate levels is contrary to previous findings, which report low adherence to medical regimens in individuals with chronic conditions, such as diabetes. 15 One possible explanation for this finding is that in our study we found that the majority of patients with type 2 diabetes were in the older age range and therefore age may contribute to these findings.
The primary indication for a parathroidectomy is an elevated parathyroid hormone level, 16 which indicates prior poor phosphate management and/or failed conventional medical therapy, therefore this may be one explanation why the patients who had not had a parathroidectomy had better phosphate control. Another explanation may be due to the effects of a 
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A Collinson et al parathroidectomy not being long-term. 17 Some of these patients may have received a PTX many years ago.
There were no significant differences found in serum phosphate levels between the patients prescribed phosphate binders and those not. This result may reflect low adherence to taking the phosphate binders 9 or may simply reflect the fact that patients with good phosphate control did not require binders. The main reason for poor adherence to phosphate binders in this study is reported as forgetfulness. Although self-reported adherence with phosphate-binding medications was low (45%), it might be expected that actual adherence is even lower.
Surprisingly there was no association between urea reduction ratio and phosphate control. Weekly removal of phosphate and middle molecules is enhanced greatly by increasing the frequency or duration of treatment sessions. 18 It might be expected that inadequate dialysis might be associated with increased incidence of hyperphosphataemia. However, the groups in this study may not have been large enough to demonstrate significance.
There were clear gaps in both patients' knowledge of foods high in phosphorus and awareness of symptoms/health consequences of hyperphosphataemia. This is supported by previous findings. 3, 19 Bananas were frequently thought of as phosphate-rich, indicating confusion over dietary advice, which is comparable to previous findings. 3 Interestingly, younger patients were generally more knowledgeable, although they had poorer phosphate control. This finding is similar to others. 20 This may reflect the fact that some of the older patients surveyed had not received low phosphate dietary advice. Phosphate restriction may have been deemed inappropriate for those patients, particularly the elderly or malnourished, with good phosphate control. Knowledge of medical consequences has been found to be a poor predictor of dietary compliance in this population. 21 The dietitian was reported to be the most useful source of information (verbal or written) on phosphate management. It has been suggested that dietary manipulation is an underappreciated tool for reducing hyperphosphataemia, 22 and dietitian led education programmes with this patient group have been highly effective in improving serum phosphate levels 23 and reducing phosphate intake and serum calcium-phosphate product. 24 The recent NICE guidelines on the management of hyperphosphataemia recommend that a specialist renal dietitian gives individualised advice to patients. 25 These guidelines emphasise the importance of tailoring the dietary advice to the individual and the inclusion of advice on food and drink with high levels of phosphate additives.
Various education strategies for improving phosphate control have been examined by others. Kuhlman et al. 26 have developed a system for teaching patients to titrate phosphate binder dose according to the phosphate content of the meal as defined in 'phosphate units', thus allowing self-adjustment and encouraging patient empowerment. Morey et al. 27 showed a significant improvement in serum phosphate at 3 months with intensive monthly dietetic input compared with standard treatment, although the difference was not sustained. In a recent paper, Kalantar-Zadeh 28 discusses a variety of educational tools, such as the traffic light scheme and the use of photo cards that can help patients visualise the appropriate food choices to help with phosphate management. A systematic review of seven randomised controlled trials with a total of 254 patients with hyperphosphataemia showed that education strategies reduced mean phosphate levels by 0.2 mmol/l. 29 The results of this study show that phosphate control remains a challenge in all HD, but particularly the younger patients, who, it could be argued, have more to lose in terms of acquiring longterm complications of hyperphosphataemia. The lack of association between knowledge and good phosphate control shown here suggests that educational methods focusing on patient motivation are needed rather than traditional approaches of information giving. The use of psycho-education in relation to phosphatebinding medication has been successfully piloted in this population. 30 New methods of motivating and engaging with patients are necessary to promote autonomy and self-management. Skills to build self-efficacy through, for example, motivational interviewing have been emphasised as important tools to aid adherence in these patients. 28 Successful strategies are also required to help patients to remember to take phosphate binders as forgetfulness was a major problem with all patients in this study.
This study suggests that the age of the patient is an important factor that needs to be considered when exploring challenges and solutions for phosphate management. In this study, it was found that younger patients were significantly more likely to use Renal Patient View to check their blood results. Therefore, using the same dietary education techniques may not be suitable for all age groups. Interactive approaches to education, supported by skilled health professionals, using technologies such as the internet and mobile telephones are now being suggested as important education tools for younger patients, extending support beyond the hospital setting, enhancing accessibility to information and improving patients' self-care management. An interactive approach to education is becoming increasingly popular in younger patients 31 and the use of interactive technology has been shown to improve patient satisfaction with educational materials. 32 A limitation of this study is the relatively small patient numbers and the inclusion of patients from only one renal unit in the UK. In addition, no data were gathered on the educational level of the patients. It is therefore recommended that data are collected from other renal units to confirm and enhance these findings.
In conclusion, phosphate management remains complex and age specific strategies are needed. Further research is necessary to investigate innovative approaches such as the use of interactive technologies supported by skilled health professionals to enable patients, particularly the younger HD patients, to manage their phosphate levels more effectively.
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